September 2, 2026

Preview to members September activities across Europe

Preview to members September activities across Europe

September is shaping up to be an extraordinary month for myeloma awareness and advocacy across MPE’s member network. From Portugal to Serbia, from Lithuania to Slovenia, our members are planning bold, impactful campaigns to raise awareness during Blood Cancer Awareness Month and European Myeloma Day on 27 September.

Key member activities include:

Portugal (APCL) is running a full month of engagement: a blood cancer awareness campaign, a specialist seminar on transplant on 12 September and a survivorship conference on 25 September, bringing together patients, carers and clinicians.

Serbia (AMPS) is taking awareness nationwide with an EMD event on 27 September and a caravan campaign driving across the country, printing and distributing the myeloma diagnosis pathway to reach GPs and primary care physicians at grassroots level.

Slovenia (DruÅ¡tvo BKB) is running their most comprehensive campaign yet: a press conference, educational lecture, information stands in 12 hospitals, a “Walk in Red” awareness event, landmark illuminations, and a photography competition as part of the Capture the Light project.

Lithuania (Kraujas) is leveraging clinical networks, publishing the MPE Myeloma Diagnosis Pathway on ‘FOCUS’ a digital platform accessed by over 5,000 GPs and family doctors, ensuring broad visibility among primary care professionals.

Russia (Mercy Bridge) is hosting a European Myeloma Day Patient School, an educational event bringing together leading haematology experts to discuss early diagnosis, innovative treatments, and patient support.

Israel (AMEN) is focusing advocacy on innovative treatments, campaigning to raise awareness of bispecific antibodies and CAR-T therapy and advocating for their inclusion in Israel’s National Health Basket.

Czech Republic (KPMM) is hosting a 2-day patient seminar and distributing the diagnosis pathway through GP-focused partner networks.

These campaigns reflect the breadth of our network and the commitment of our members to putting myeloma and AL amyloidosis on the European health agenda. From public awareness events to clinician engagement, from survivorship support to innovative treatment advocacy, our members are driving real change.

If you would like to share your member organisation’s September plans, or if you need support materials for your own BCAM or EMD activities, please get in touch.

Thank you to all our members for your dedication and leadership!